Browsing “Press Releases | EVERSANA”

Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™

Agreement outlines commercialization and distribution execution strategy upon FDA approval EVERSANA to provide commercial services of approximately $250 million over 5 years FREMONT, Calif., August 6, 2020 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced it has partnered with EVERSANA, a leading provider of commercial services to the life science […]

EVERSANA™ and Havas Health & You announce exclusive strategic partnership, optimizing global data & analytics platform, expansive network reach and commercialization expertise for life sciences category

CHICAGO – July 30, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, and Havas Health & You (HH&Y), the world’s largest global health and wellness network, today announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and […]

Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO, Illinois – July 29, 2020 – Vineti, the California-based company that offers a digital platform to enable broad access to advanced therapeutics, and EVERSANA™, a provider of global integrated commercial services to the life science […]

EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments

CHICAGO – July 23, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. ICER is an independent nonprofit […]

EVERSANA™ appoints Kelly Baker to Chief Financial Officer

Seasoned financial executive to shepherd global growth and scale of commercial service platform CHICAGO – May 4, 2020 – EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Kelly Baker to Chief Financial Officer (CFO). Baker will direct the company’s financial excellence and lead the […]

EVERSANA™ launches data & analytics business to drive next-generation integrated commercial services

Company appoints healthcare data & analytics innovator Brigham Hyde, Ph.D. to lead platform launch CHICAGO – April 23, 2020 – EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Brigham Hyde, Ph.D. to President, Data & Analytics (D&A). Hyde will lead the company’s expansion into […]

EVERSANA™ appoints digital therapeutics pioneer Ed Cox to lead global commercialization platform for digital medicine

CHICAGO – March 18, 2020  – EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Ed Cox to Executive Vice President, Strategic Alliances & Global Head of EVERSANA’s new Digital Medicine practice area. Widely recognized as a preeminent thought leader in digital therapeutics, Cox joins […]

EVERSANA™ unveils EVERSANA CONSULTING, portfolio of consulting services to solve challenges across the life sciences sector

CHICAGO – February 6, 2020  – Fueled by the growing demand for seasoned consulting expertise, EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today unveiled EVERSANA CONSULTING, the new name of its global consulting services focused on the pharmaceutical and biotechnology industries. EVERSANA CONSULTING is built to address challenges across […]

Evoke Pharma Enters Commercialization Agreement with EVERSANA for Gimoti™

EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, CA, and CHICAGO, IL. January 23, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, an independent provider of global commercial services […]

EVERSANA and Noom announce strategic partnership to improve therapy adherence and patient engagement for complex therapies

CHICAGO – January 9, 2020  – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, and Noom, the world’s leading behavior change company, today announced a collaboration to increase medication adherence and improve health outcomes for the millions of patients suffering from chronic conditions and rare diseases worldwide. The partnership combines […]